Fexuprazan Phase 3 results
Caption Fexuprazan Phase 3 results
Source Daewoong Pharmaceutical Co., Ltd
Download
Related Press Releases Links Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker